SIRAVYADHA FOLLOWED BY AGNIKARMA IN SCIATICA FOR PAIN MANAGEMENT

EVALUATION OF ADD ON EFFICACY OF AGNIKARMA WITH SIRAVYADHA IN PAIN MANAGEMENT OF GRIDHRASI W.S.R TO SCIATICA- A RANDOMIZED COMPARATIVE CLINICAL STUDY

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/08/027473

Enrollment

Registered

2020-08-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

Intervention1: SIRAVYADHA FOLLOWED BY AGNIKARMA: DOSE-SIRAVYADHA SINGLE ADMINISTRATION FOLLOWED BY AGNIKARMA SINGLE ADMINISTRATION FEQUENCY-SIRAVYADHA SINGLE TIME FOLLOWED BY AGNIKARMA SINGLE TIME ROU

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with classical features of Gridhrasi 1.Sphik-parsva-kati-prishta-uru-janu-janga-padamkramat â??Sthamba, Ruja & toda 2.Spandana 3.Saktikshepana nigrahanti 4.Janu-uru sandhi sphurana 5.Subjects with either Sex and Age between 20 â?? 60 years. 6.Yogya for Siravyadha and Agnikarma. 7.Subjects with normal CT ,BT and Hb%

Exclusion criteria

Exclusion criteria: 1)Ayogya for Siravyadha and Agnikarma 2)Subjects with H/O spinal tuberculosis/lesion/ injury, HIV I&II, HbsAG infections, severe anaemia or any other chronic illness (Like Diabetes ,Hypertension etc) and pregnancy Subjects with K/C/O bleeding disorders

Design outcomes

Primary

Measure	Time frame
PAIN MANAGEMENTTimepoint: Immediately after administration,After 1 hour 3rd hour,6th hour,12th hour and 24th hour of administration	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDRPRADEEP S SHINDHE

KAHERs SHRI B M K AYURVEDA MAHAVIDYALAYA, SHAHAPUR,BELAGAVI

pshindhe@gmail.com9986331357

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026